{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:07:28Z","timestamp":1790820448373,"version":"4.1.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S1047951126123622_as1\">\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>\n                      Hypertrophic cardiomyopathy is a life-threatening disease with limited studies in Middle Eastern populations. This pilot study (\n                      <jats:italic>n<\/jats:italic>\n                      = 8) aimed to identify rare genetic variants to enable future presymptomatic diagnosis and primary prevention. While the sample size precludes establishing population-level prevalence, our findings provide a springboard for generating testable hypotheses for future multicenter trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126123622_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Whole-exome sequencing was performed on eight unrelated Egyptian patients. We prioritised variants using stringent criteria: allele frequency &lt; 0.01 in gnomAD, combined annotation dependent depletion (CADD) score &gt; 10, and focused analysis of 29 genes with definitive or moderate evidence for hypertrophic cardiomyopathy causation according to Clinical Genome Resource (ClinGen). Variants were ACMG\/AMP-classified and correlated with detailed clinical phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126123622_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We identified 21 rare variants across 10 hypertrophic cardiomyopathy-associated genes. Core sarcomeric genes accounted for seven variants:\n                      <jats:italic>MYBPC3<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 2; one likely pathogenic, p.Gly1206Asp),\n                      <jats:italic>MYH7<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 2; one pathogenic, p.Phe252Ser), and\n                      <jats:italic>TNNT2<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 3; all variants of uncertain significance). Additionally, likely pathogenic variants were found in\n                      <jats:italic>PLN<\/jats:italic>\n                      (p.Arg25Cys) and\n                      <jats:italic>KLHL24<\/jats:italic>\n                      (p.Arg103*). Patients with pathogenic or likely pathogenic sarcomeric variants exhibited severe phenotypes, including septal thickness up to 30 mm, left ventricular outflow tract gradients up to 60 mmHg, and a high arrhythmic burden, influencing decisions like implantable cardioverter-defibrillator implantation and myectomy. Notably, all three\n                      <jats:italic>TNNT2<\/jats:italic>\n                      carriers manifested atrial fibrillation or non-sustained ventricular tachycardia, reinforcing its arrhythmic risk. Four novel or likely pathogenic variants were submitted to ClinVar.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126123622_as4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>As the first genetic study of hypertrophic cardiomyopathy in an Egyptian population, this work expands the global mutational spectrum, demonstrates the utility of genetic testing for risk stratification and personalised management, and underscores the need to diversify genomic datasets for equitable precision medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s1047951126123622","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:18:32Z","timestamp":1784629112000},"page":"1361-1372","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Whole-exome sequencing identifies rare genetic variants in Egyptian patients with hypertrophic cardiomyopathy: a pilot study"],"prefix":"10.1017","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0051-9159","authenticated-orcid":false,"given":"Rana E.","family":"Negm","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q21mh05","id-type":"ROR","asserted-by":"publisher"}],"name":"Cairo University Faculty of Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refaat M.","family":"Gabre","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q21mh05","id-type":"ROR","asserted-by":"publisher"}],"name":"Cairo University Faculty of Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El-Sherif","sequence":"additional","affiliation":[{"name":"Cairo University Faculty of Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.","family":"Katta","sequence":"additional","affiliation":[{"name":"National Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"El-Sayed","sequence":"additional","affiliation":[{"name":"National Research Centre"},{"name":"Egypt Center for Research and Regenerative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"ElHefnawi","sequence":"additional","affiliation":[{"name":"National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"S1047951126123622_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1097-3"},{"key":"S1047951126123622_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.12.010"},{"key":"S1047951126123622_ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001666"},{"key":"S1047951126123622_ref36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605317103"},{"key":"S1047951126123622_ref11","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951120003157"},{"key":"S1047951126123622_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pld.2024.04.001"},{"key":"S1047951126123622_ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-025-11323-4"},{"key":"S1047951126123622_ref23","first-page":"742","article-title":"Emerging themes in genetics of hypertrophic cardiomyopathy: current status and clinical application","volume":"40","author":"Garc\u00eda-Hern\u00e1ndez","year":"2024","journal-title":"Can J Cardiol"},{"key":"S1047951126123622_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab249"},{"key":"S1047951126123622_ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103397"},{"key":"S1047951126123622_ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13157"},{"key":"S1047951126123622_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2023.102822"},{"key":"S1047951126123622_ref1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S365001"},{"key":"S1047951126123622_ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914572"},{"key":"S1047951126123622_ref14","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/bioinformatics\/btac137","article-title":"BWA-MEME: BWA-MEM emulated with a machine learning approach","volume":"38","author":"Youngmok","year":"2022","journal-title":"Bioinformatics"},{"key":"S1047951126123622_ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56154-7"},{"key":"S1047951126123622_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.021"},{"key":"S1047951126123622_ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-024-00600-4"},{"key":"S1047951126123622_ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1236539"},{"key":"S1047951126123622_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.011"},{"key":"S1047951126123622_ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-02000-8"},{"key":"S1047951126123622_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00750-9"},{"key":"S1047951126123622_ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1480947"},{"key":"S1047951126123622_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107558"},{"key":"S1047951126123622_ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-022-00284-y"},{"key":"S1047951126123622_ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01246-8"},{"key":"S1047951126123622_ref30","first-page":"e20240058","article-title":"Exploring the role of ALPK3 variants in hypertrophic and dilated cardiomyopathies","volume":"5","author":"Andrade","year":"2025","journal-title":"ABC Heart Fail Cardiomyop"},{"key":"S1047951126123622_ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00608-2"},{"key":"S1047951126123622_ref17","doi-asserted-by":"publisher","DOI":"10.4161\/fly.19695"},{"key":"S1047951126123622_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.10.032"},{"key":"S1047951126123622_ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1167256"},{"key":"S1047951126123622_ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tvjl.2010.09.029","article-title":"Candidate genes for physical performance in the horse","volume":"190","author":"Wiebke","year":"2011","journal-title":"Vet J"},{"key":"S1047951126123622_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00817"},{"key":"S1047951126123622_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101730"},{"key":"S1047951126123622_ref12","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Elena","year":"2023","journal-title":"Eur Heart J"},{"key":"S1047951126123622_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suae108"},{"key":"S1047951126123622_ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1626242"},{"key":"S1047951126123622_ref3","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i1.99595"},{"key":"S1047951126123622_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107276"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951126123622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:46:25Z","timestamp":1790819185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951126123622\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1047951126123622"],"URL":"https:\/\/doi.org\/10.1017\/s1047951126123622","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}